Skip to main content

Baricitinib for Remission Induction and Glucocorticoid Sparing in New-Onset PMR

Dr. Mrinalini Dey reviews LB0005 presented at EULAR 2026 in London

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×